Pomerantz LLP Files Investor Lawsuit Against Fractyl Health, Inc. – ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 16, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ:GUTS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-07167, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations ..

Singmed Showcases Pulmonary and Nasal Platforms for Inhaled mRNA, Biologics and Nose-to-Brain Delivery

Armor Health Expands Structured Approach to Women's Postpartum Mental Health in Correctional Settings

MIAMI, Sept. 16, 2026 /PRNewswire/ -- Armor Health (ArmorHealthcare.com), a national provider of correctional healthcare, is expanding its distinct, structured approach to addressing postpartum depression (PPD) among women in correctional settings, where postpartum patients face...

Robinson Pharma, Inc. Receives "Above and Beyond" Supplier Award from Bausch + Lomb for September 2026

SANTA ANA, Calif., Sept. 16, 2026 /PRNewswire/ -- Robinson Pharma, Inc. (RPI), a premier full-service contract manufacturer of dietary supplements and nutraceuticals, is proud to announce that it has been honored by Bausch + Lomb with the "Above and Beyond" Supplier Award for the month of...

30 Organizations, 7 Nations, 1 Problem: My Normative Enters Next Phase to Address the Trillion Dollar Global Women’s Health Equity Gap

CALGARY, Alberta, September 16, 2026--Modern Medicine has lacked a shared language to fully serve Women’s Health, until now.

Cumulus Neuroscience Presents Data at the ISCTM 2026 Autumn Conference

Interim data show high adherence and usability for remote, multimodal brain monitoring in borderline personality disorder and therapy-resistant depression, and a two-minute digital cognitive task performing comparably to clinical benchmarks for Alzheimer's trial pre-enrichment. BELFAST,...

WesternU Oregon develops new pathway agreement with Sonoma State University

LEBANON, Ore., Sept. 16, 2026 /PRNewswire/ -- Western University of Health Sciences (WesternU) has partnered with Sonoma State University to develop a new pathway program for students interested in physical therapy or osteopathic medicine. Through this new partnership with WesternU...

AN2 Therapeutics, Inc. Reports Inducement Grants under Listing Rule 5635(c)(4)

MENLO PARK, Calif., September 16, 2026--AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical-stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today announced it granted inducement equity awards to Cameron Trenor, M.D., the Company’s newly-appointed Chief Medical Officer.

Greenberg Traurig Advises National Healthcare Properties on Senior Housing Acquisitions in Multiple States

NEW YORK, Sept. 16, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, LLP represented National Healthcare Properties, Inc. (Nasdaq: NHP), a self-managed real estate investment trust focused on acquiring, owning, and investing in a diversified portfolio of health care real estate, in...

Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)

Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for HLHS

Adora Life Science Announces the Appointment of Dr. Clinton D. Morgan as Chief Medical Officer

FRANKLIN, Tenn., Sept. 16, 2026 /PRNewswire/ -- Adora Life Science (Adora) today announced that Dr. Clinton D. Morgan, MD, will be joining Adora as its full-time Chief Medical Officer, effective November 1, 2026. Dr. Morgan has previously been appointed to Adora's Board of Directors and...

BIONATION 2026 to Bring Canada’s Life Sciences Sector Together in Ottawa

OTTAWA, Ontario, September 16, 2026--BIOTECanada will host BIONATION at the National Arts Centre in Ottawa, bringing together some 160 biotechnology and life sciences leaders, policymakers, elected officials, investors, researchers, and sector partners for two days of discussion on the issues shaping the future of Canadian biotech.